Nuclear localization of β-catenin in Sertoli cell tumors and other sex cord-stromal tumors of the testis: An immunohistochemical study of 87 cases

American Journal of Surgical Pathology

Volumn 39, Issue 10, 2015, Pages 1390-1394

  Zhang, Chen ^a   Ulbright, Thomas M ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Immunohistochemistry; Sertoli cell tumor; Sex cord stromal tumor; Testicular neoplasms; catenin

Indexed keywords

BETA CATENIN; CTNNB1 PROTEIN, HUMAN; TUMOR MARKER;

CELL NUCLEUS; CHEMISTRY; CLASSIFICATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PATHOLOGY; PREDICTIVE VALUE; SERTOLI CELL TUMOR; SEX CORD TUMOR; TESTIS TUMOR;

BETA CATENIN; BIOMARKERS, TUMOR; CELL NUCLEUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PREDICTIVE VALUE OF TESTS; SERTOLI CELL TUMOR; SEX CORD-GONADAL STROMAL TUMORS; TESTICULAR NEOPLASMS;

EID: 84941772371     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000455     Document Type: Article

References (27)

1. Young RH, Koelliker DD, Scully RE. Sertoli cell tumors of the testis, not otherwise specified: a clinicopathologic analysis of 60 cases. Am J Surg Pathol. 1998;22:709-721.
2. Ulbright TM, Amin MB, Young RH. Intratubular large cell hyalinizing Sertoli cell neoplasia of the testis: a report of 8 cases of a distinctive lesion of the Peutz-Jeghers syndrome. Am J Surg Pathol. 2007;31:827-835.
3. Kratzer SS, Ulbright TM, Talerman A, et al. Large cell calcifying Sertoli cell tumor of the testis: contrasting features of six malignant and six benign tumors and a review of the literature. Am J Surg Pathol. 1997;21:1271-1280.
4. Zukerberg LR, Young RH, Scully RE. Sclerosing Sertoli cell tumor of the testis. A report of 10 cases. Am J Surg Pathol. 1991;15:829-834.
5. Kao CS, Kum JB, Idrees MT, et al. Sclerosing Sertoli cell tumor of the testis: a clinicopathologic study of 20 cases. Am J Surg Pathol. 2014;38:510-517.
6. Kao CS, Cheng L, Ulbright TM, et al. The utility of SOX9, FOXL2, and SF1 immunohistochemical (IHC) stains in the diagnosis of testicular sex cord-stromal tumors (SCST) compared to other commonly used markers (abstract). Mod Pathol. 2015;28:233A.
7. Sasano H, Nakashima N, Matsuzaki O, et al. Testicular sex cordstromal lesions: immunohistochemical analysis of cytokeratin, vimentin and steroidogenic enzymes. Virchows Arch A Pathol Anat Histopathol. 1992;421:163-169.
8. Perez-Moreno M, Jamora C, Fuchs E. Sticky business: orchestrating cellular signals at adherens junctions. Cell. 2003;112:535-548.
9. Alman BA, Li C, Pajerski ME, et al. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol. 1997;151:329-334.
10. Koch A, Denkhaus D, Albrecht S, et al. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Cancer Res. 1999;59:269-273.
11. Tanaka Y, Kato K, Notohara K, et al. Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solidpseudopapillary neoplasm. Cancer Res. 2001;61:8401-8404.
12. Maeda D, Shibahara J, Sakuma T, et al. β-catenin (CTNNB1) S33C mutation in ovarian microcystic stromal tumors. Am J Surg Pathol. 2011;35:1429-1440.
13. Irving JA, Lee C-H, Yip S, et al. Microcystic stromal tumor of the ovary: a distinct ovarian stromal neoplasm characterized by FOXL2, SF-1, WT-1, cyclin D1, and beta-catenin nuclear expression and CTNNB1 mutations (abstract). Mod Pathol. 2014;27:287A.
14. Lassila M, Juhila J, Heikkila E, et al. Densin is a novel cell membrane protein of Sertoli cells in the testis. Mol Reprod Dev. 2007;74:641-645.
15. Perrone F, Bertolotti A, Montemurro G, et al. Frequent mutation and nuclear localization of beta-catenin in Sertoli cell tumors of the testis. Am J Surg Pathol. 2014;38:66-71.
16. Colecchia M. Observations on the paper "sclerosing Sertoli cell tumor of the testis: a clinicopathologic study of 20 cases" by Kao et al. Am J Surg Pathol. 2014;38:1160.
17. Xiao GQ, Granato RC, Unger PD. Bilateral Sertoli cell tumors of the testis-a likely new extracolonic manifestation of familial adenomatous polyposis. Virchows Arch. 2012;461:713-715.
18. Ulbright TM, Young RH. Sex cord-stromal tumors. In: Ulbright TM, Young RH, eds. AFIP Atlas of Tumor Pathology: Tumors of the Testis and Adjacent Structures. Silver Spring, MD: American Registry of Pathology; 2013:273.
19. Petersson F, Bulimbasic S, Sima R, et al. Large cell calcifying Sertoli cell tumor: a clinicopathologic study of 1 malignant and 3 benign tumors using histomorphology, immunohistochemistry, ultrastructure, comparative genomic hybridization, and polymerase chain reaction analysis of the PRKAR1A gene. Hum Pathol. 2010;41: 552-559.
20. Oda H, Uemura T, Shiomi K, et al. Identification of a Drosophila homologue of alpha-catenin and its association with the armadillo protein. J Cell Biol. 1993;121:1133-1140.
21. Ozawa M, Baribault H, Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 1989;8:1711-1717.
22. Behrens J, Jerchow BA, Wurtele M, et al. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science. 1998;280:596-599.
23. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science. 1997;275:1784-1787.
24. Harris TJ, Peifer M. Decisions, decisions: beta-catenin chooses between adhesion and transcription. Trends Cell Biol. 2005;15: 234-237.
25. Morin PJ, Sparks AB, Korinek V, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 1997;275:1787-1790.
26. Tanwar PS, Zhang L, Tanaka Y, et al. Focal Mullerian duct retention in male mice with constitutively activated beta-catenin expression in the Mullerian duct mesenchyme. Proc Natl Acad Sci USA. 2010;107:16142-16147.
27. Chang H, Guillou F, Taketo MM, et al. Overactive beta-catenin signaling causes testicular Sertoli cell tumor development in the mouse. Biol Reprod. 2009;81:842-849.